Lower urinary tract obstruction: fetal intervention based on prenatal staging

Rodrigo Ruano, Timothy Dunn, Michael C. Braun, Joseph R. Angelo, Adnan Safdar

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The authors present an overview of lower urinary tract obstruction (LUTO) in the fetus with a particular focus on the insult to the developing renal system. Diagnostic criteria along with the challenges in estimating long-term prognosis are reviewed. A proposed prenatal LUTO disease severity classification to guide management decisions with fetal intervention to maintain or salvage in utero and neonatal pulmonary and renal function is also discussed. Stage I LUTO (mild form) is characterized by normal amniotic fluid index after 18 weeks, normal kidney echogenicity, no renal cortical cysts, no evidence of renal dysplasia, and favorable urinary biochemistries when sampled between 18 and 30 weeks; prenatal surveillance is recommended. Stage II LUTO is characterized by oligohydramnios/anhydramnios, hyperechogenic kidneys but absent renal cortical cysts or apparent signs of renal dysplasia and favorable fetal urinary biochemistry; fetal vesicoamniotic shunting (VAS) or fetal cystoscopy is indicated to prevent pulmonary hypoplasia and renal failure. Stage III LUTO is oligohydramnios/anhydramnios, hyperechogenic kidneys with cortical cysts and renal dysplasia and unfavorable fetal urinary biochemistry after serial evaluation; fetal vesicoamniotic shunt may prevent severe pulmonary hypoplasia but not renal failure. Stage IV is characterized by intrauterine fetal renal failure, defined by anhydramnios and ultrasound (US) findings suggestive of severe renal dysplasia, and is associated with death in 24 h of life or end-stage renal disease (ESRD) within the first week of life; fetal vesicoamniotic shunt and fetal cystoscopy are not indicated.

Original languageEnglish (US)
Pages (from-to)1871-1878
Number of pages8
JournalPediatric Nephrology
Volume32
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Urinary Tract
Kidney
Biochemistry
Oligohydramnios
Renal Insufficiency
Cysts
Cystoscopy
Lung
Urologic Diseases
Amniotic Fluid
Chronic Kidney Failure
Fetus

Keywords

  • Fetal cystoscopy
  • Fetal intervention
  • Fetus
  • Lower urinary tract obstruction
  • LUTO

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Nephrology

Cite this

Lower urinary tract obstruction : fetal intervention based on prenatal staging. / Ruano, Rodrigo; Dunn, Timothy; Braun, Michael C.; Angelo, Joseph R.; Safdar, Adnan.

In: Pediatric Nephrology, Vol. 32, No. 10, 01.10.2017, p. 1871-1878.

Research output: Contribution to journalArticle

Ruano, Rodrigo ; Dunn, Timothy ; Braun, Michael C. ; Angelo, Joseph R. ; Safdar, Adnan. / Lower urinary tract obstruction : fetal intervention based on prenatal staging. In: Pediatric Nephrology. 2017 ; Vol. 32, No. 10. pp. 1871-1878.
@article{72ba3d565d384a7ea90c5e325d7a4ca3,
title = "Lower urinary tract obstruction: fetal intervention based on prenatal staging",
abstract = "The authors present an overview of lower urinary tract obstruction (LUTO) in the fetus with a particular focus on the insult to the developing renal system. Diagnostic criteria along with the challenges in estimating long-term prognosis are reviewed. A proposed prenatal LUTO disease severity classification to guide management decisions with fetal intervention to maintain or salvage in utero and neonatal pulmonary and renal function is also discussed. Stage I LUTO (mild form) is characterized by normal amniotic fluid index after 18 weeks, normal kidney echogenicity, no renal cortical cysts, no evidence of renal dysplasia, and favorable urinary biochemistries when sampled between 18 and 30 weeks; prenatal surveillance is recommended. Stage II LUTO is characterized by oligohydramnios/anhydramnios, hyperechogenic kidneys but absent renal cortical cysts or apparent signs of renal dysplasia and favorable fetal urinary biochemistry; fetal vesicoamniotic shunting (VAS) or fetal cystoscopy is indicated to prevent pulmonary hypoplasia and renal failure. Stage III LUTO is oligohydramnios/anhydramnios, hyperechogenic kidneys with cortical cysts and renal dysplasia and unfavorable fetal urinary biochemistry after serial evaluation; fetal vesicoamniotic shunt may prevent severe pulmonary hypoplasia but not renal failure. Stage IV is characterized by intrauterine fetal renal failure, defined by anhydramnios and ultrasound (US) findings suggestive of severe renal dysplasia, and is associated with death in 24 h of life or end-stage renal disease (ESRD) within the first week of life; fetal vesicoamniotic shunt and fetal cystoscopy are not indicated.",
keywords = "Fetal cystoscopy, Fetal intervention, Fetus, Lower urinary tract obstruction, LUTO",
author = "Rodrigo Ruano and Timothy Dunn and Braun, {Michael C.} and Angelo, {Joseph R.} and Adnan Safdar",
year = "2017",
month = "10",
day = "1",
doi = "10.1007/s00467-017-3593-8",
language = "English (US)",
volume = "32",
pages = "1871--1878",
journal = "Pediatric nephrology (Berlin, Germany)",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Lower urinary tract obstruction

T2 - fetal intervention based on prenatal staging

AU - Ruano, Rodrigo

AU - Dunn, Timothy

AU - Braun, Michael C.

AU - Angelo, Joseph R.

AU - Safdar, Adnan

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The authors present an overview of lower urinary tract obstruction (LUTO) in the fetus with a particular focus on the insult to the developing renal system. Diagnostic criteria along with the challenges in estimating long-term prognosis are reviewed. A proposed prenatal LUTO disease severity classification to guide management decisions with fetal intervention to maintain or salvage in utero and neonatal pulmonary and renal function is also discussed. Stage I LUTO (mild form) is characterized by normal amniotic fluid index after 18 weeks, normal kidney echogenicity, no renal cortical cysts, no evidence of renal dysplasia, and favorable urinary biochemistries when sampled between 18 and 30 weeks; prenatal surveillance is recommended. Stage II LUTO is characterized by oligohydramnios/anhydramnios, hyperechogenic kidneys but absent renal cortical cysts or apparent signs of renal dysplasia and favorable fetal urinary biochemistry; fetal vesicoamniotic shunting (VAS) or fetal cystoscopy is indicated to prevent pulmonary hypoplasia and renal failure. Stage III LUTO is oligohydramnios/anhydramnios, hyperechogenic kidneys with cortical cysts and renal dysplasia and unfavorable fetal urinary biochemistry after serial evaluation; fetal vesicoamniotic shunt may prevent severe pulmonary hypoplasia but not renal failure. Stage IV is characterized by intrauterine fetal renal failure, defined by anhydramnios and ultrasound (US) findings suggestive of severe renal dysplasia, and is associated with death in 24 h of life or end-stage renal disease (ESRD) within the first week of life; fetal vesicoamniotic shunt and fetal cystoscopy are not indicated.

AB - The authors present an overview of lower urinary tract obstruction (LUTO) in the fetus with a particular focus on the insult to the developing renal system. Diagnostic criteria along with the challenges in estimating long-term prognosis are reviewed. A proposed prenatal LUTO disease severity classification to guide management decisions with fetal intervention to maintain or salvage in utero and neonatal pulmonary and renal function is also discussed. Stage I LUTO (mild form) is characterized by normal amniotic fluid index after 18 weeks, normal kidney echogenicity, no renal cortical cysts, no evidence of renal dysplasia, and favorable urinary biochemistries when sampled between 18 and 30 weeks; prenatal surveillance is recommended. Stage II LUTO is characterized by oligohydramnios/anhydramnios, hyperechogenic kidneys but absent renal cortical cysts or apparent signs of renal dysplasia and favorable fetal urinary biochemistry; fetal vesicoamniotic shunting (VAS) or fetal cystoscopy is indicated to prevent pulmonary hypoplasia and renal failure. Stage III LUTO is oligohydramnios/anhydramnios, hyperechogenic kidneys with cortical cysts and renal dysplasia and unfavorable fetal urinary biochemistry after serial evaluation; fetal vesicoamniotic shunt may prevent severe pulmonary hypoplasia but not renal failure. Stage IV is characterized by intrauterine fetal renal failure, defined by anhydramnios and ultrasound (US) findings suggestive of severe renal dysplasia, and is associated with death in 24 h of life or end-stage renal disease (ESRD) within the first week of life; fetal vesicoamniotic shunt and fetal cystoscopy are not indicated.

KW - Fetal cystoscopy

KW - Fetal intervention

KW - Fetus

KW - Lower urinary tract obstruction

KW - LUTO

UR - http://www.scopus.com/inward/record.url?scp=85025113818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025113818&partnerID=8YFLogxK

U2 - 10.1007/s00467-017-3593-8

DO - 10.1007/s00467-017-3593-8

M3 - Article

C2 - 28730376

AN - SCOPUS:85025113818

VL - 32

SP - 1871

EP - 1878

JO - Pediatric nephrology (Berlin, Germany)

JF - Pediatric nephrology (Berlin, Germany)

SN - 0931-041X

IS - 10

ER -